City National Bank’s Teva Pharmaceuticals TEVA Stock Holding History

City National Bank’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$890K	Buy	15,770 +2,810	+22%	+$182K	0.01%	470
2015 Q2	$766K	Buy	12,960 +28	+0.2%	+$1.73K	0.01%	533
2015 Q1	$806K	Buy	12,932 +1,245	+11%	+$72.4K	0.01%	529
2014 Q4	$672K	Sell	11,687 -8,906	-43%	-$496K	0.01%	576
2014 Q3	$1.11M	Buy	20,593 +8,498	+70%	+$450K	0.01%	484
2014 Q2	$634K	Buy	12,095 +4,310	+55%	+$220K	0.01%	606
2014 Q1	$411K	Sell	7,785 -785	-9%	-$36.3K	0.01%	580
2013 Q4	$343K	Sell	8,570 -249	-3%	-$9.8K	0.01%	642
2013 Q3	$333K	Sell	8,819 -750	-8%	-$29.3K	0.01%	575
2013 Q2	$375K	Buy	+9,569	New	+$373K	0.01%	574

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

City National Bank's TEVA Position: Q3 2015 in Review

City National Bank increased its Teva Pharmaceuticals (TEVA) stake by 22% in Q3 2015, buying an estimated $182K and bringing the position to 15,770 shares worth $890K. The position accounts for 0.01% of the portfolio, ranked #470.

City National Bank first reported a position in TEVA in Q2 2013 and has held it in 10 quarters since. The position peaked at $1.11M in Q3 2014. 824 funds tracked by Wall St. Rank hold TEVA as of Q3 2015.

City National Bank held 15,770 shares of Teva Pharmaceuticals worth $890K as of Q3 2015.
City National Bank bought 2,810 Teva Pharmaceuticals shares in Q3 2015, an estimated $182K.
Teva Pharmaceuticals made up 0.01% of City National Bank's portfolio in Q3 2015, its #470 holding.
City National Bank first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 10 quarters since.
City National Bank's Teva Pharmaceuticals position peaked at $1.11M in Q3 2014.
824 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2015.

Based on City National Bank's 13F filing for Q3 2015, filed 29 Oct 2015.